First multi-locus timetree of seabreams and porgies (Percomorpha: Sparidae)

<div><p></p><p>Sparid fishes represent one of the major radiations of predominantly temperate-water benthic fishes. Previous molecular phylogenetic studies suggested that many traditional taxonomic groups, often based on dentition characters, do not correspond to monophyletic groups, suggesting repeated convergence in trophic ecology. In spite of the rich sparid fossil record, no comprehensive, multi-locus timetree based on sparid fossils currently exists for this group. We used a supermatrix approach to assemble a dataset of five loci and 91 sparid species, and time-calibrated this new phylogeny using eight sparid fossils. Our study corroborates the non-monophyly of the traditional sparids without the inclusion of the family Centracanthidae, as well as that of many sparid genera. Based on phylogenetic comparative analyses we find robust support for a scenario of multiple radiations and suggest that these were driven by the invasion of multiple geographic regions by different lineages, as well as by the transition to different trophic ecologies.</p></div

First timetree of Sphyraenidae (Percomorpha) reveals a Middle Eocene crown age and an Oligo–Miocene radiation of barracudas

<div><p></p><p>The 27 extant species of the family Sphyraenidae represent one of the major groups of piscivorous teleost fishes in tropical and subtropical marine waters. In spite of their ecological importance, currently, no phylogenetic hypothesis is available for this group, and we do not know the tempo of evolution of this clade. In this study, we used a supermatrix approach to assemble a dataset of three mitochondrial loci for 20 sphyraenid species, and time-calibrated this new phylogeny. Our study supports the existence of three main groups of barracudas, which we labelled the “<i>S. barracuda</i>” group, the “<i>S. obtusata</i>” group and the “<i>S. sphyraena</i>” group. The timetree indicates a Late Paleocene age (~57 Ma) for the origin of the groups, and a Middle Eocene (~45 Ma) timing for the beginning of the radiation of extant lineages. Most extant species appear to belong to phylogenetic lineages dating to the Miocene (~5 to 23 Ma). Our study reveals multiple shifts between coral reef-associated and non-reef (usually more pelagic) habitats, as well as two independent origins of large body size within this group.</p></div

Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting.

Importance: The optimal timing of discontinuation of ticagrelor before cardiac surgery is controversial. Objective: To evaluate the safety of preoperative use of ticagrelor with or without aspirin in patients with acute coronary syndromes (ACS) undergoing isolated coronary artery bypass grafting (CABG) compared with aspirin alone. Design, Setting, and Participants: This prospective, multicenter clinical trial was performed at 15 European centers of cardiac surgery. Participants were patients with ACS undergoing isolated CABG from the European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) registry between January and September 2015. Exposures: Before surgery, patients received ticagrelor with or without aspirin or aspirin alone. Main Outcomes and Measures: Severe bleeding as defined by the Universal Definition of Perioperative Bleeding (UDPB) and E-CABG bleeding classification criteria. A propensity score-matched analysis was performed to adjust for differences in baseline and operative covariates. Results: Of 2482 patients from the E-CABG registry, the study cohort included 786 (31.7%) consecutive patients with ACS (mean [SD] age, 67.1 [9.3] years; range, 32-88 years), and 132 (16.8%) were female. One-to-one propensity score matching provided 215 pairs, whose baseline and operative covariates had a standardized difference of less than 10%. Preoperative use of ticagrelor was associated with a similar risk of bleeding according to the UDPB and E-CABG bleeding classifications, but the incidence of platelet transfusion was higher in the ticagrelor group (13.5% [29 of 215] vs 6.0% [13 of 215]. Compared with those receiving aspirin alone, continuing ticagrelor up to the time of surgery or discontinuing its use less than 2 days before surgery was associated with a higher risk of platelet transfusion (22.7% [5 of 22] vs 6.4% [12 of 187]) and E-CABG bleeding grades 2 and 3 (18.2% [4 of 22] vs 5.9% [11 of 187]) and tended to have an increased risk of UDPB grades 3 and 4 (22.7% [5 of 22] vs 9.6% [18 of 187]). Among patients in whom antiplatelet drug use was discontinued at least 2 days before surgery, the incidence of platelet transfusion was 12.4% (24 of 193) in the ticagrelor group and 3.6% (1 of 28) in the aspirin-alone group. Conclusions and Relevance: In propensity score-matched analyses among patients with ACS undergoing CABG, the use of preoperative ticagrelor with or without aspirin compared with aspirin alone was associated with more platelet transfusion but similar degree of bleeding; in patients receiving ticagrelor 1 day before or up until surgery, there was an increased rate of severe bleeding